HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

FTV

Fortive Corporation (S&P 500)

Technology — Scientific & Technical Instruments

Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including maintenance, repair, measurement and condition monitoring, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, and SERVICECHANNEL brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, FLUKE BIOMEDICAL, LANDAUER, and PROVATION brand names. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.

Hold 2.8 / 5 14 analysts
$55.84
+$1.03 (+1.88%)
Target: $64.00 (14.6%)

Price History

52-Week Range
Sign in to add FTV to a watchlist or set price alerts.

Fundamentals

Market Cap$16.86B
P/E Ratio (TTM)29.54
Forward P/E17.18
EPS (TTM)$1.89
Dividend Yield0.51%
Profit Margin12.38%
Revenue Growth7.90%
ROE7.32%
Debt/Equity59.28
Recommendation Hold 2.8
Analyst Target$64.00
Analysts14
Next Earnings Oct 28, 2026 BMO
Indexes S&P 500

Technical Indicators

RSI (14)57.0
Beta0.97
SMA 20$55.68
SMA 40$57.88
52-Week High$64.56
52-Week Low$47.71
50-Day Avg$58.56
200-Day Avg$58.27
Avg Volume$2.43M
Volume$2.15M

Performance Analysis

NEUTRAL

FTV presents a mixed picture with both positive and negative indicators.

~ Trading at 48% of its 52-week range.
+ RSI at 57.0 shows positive momentum.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
~ Modest revenue growth of 7.9% year-over-year.
~ Wall Street consensus is "Hold" from 14 analysts.
+ Average analyst target of $64.00 implies 14.6% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Oct 01, 2026 21:01 UTC

Back to Screener Export Report